GM-CSF reduces expression of chondroitin sulfate proteoglycan (CSPG) core proteins in TGF-β-treated primary astrocytes |
Choi, Jung-Kyoung
(Department of Physiology, Inha University College of Medicine)
Park, Sang-Yoon (Department of Science in Korean Medicine, Cancer Preventive Material Development Research Center, College of Korean Medicine, Kyung Hee University) Kim, Kil Hwan (Department of Physiology, Inha University College of Medicine) Park, So Ra (Department of Physiology, Inha University College of Medicine) Lee, Seok-Geun (Department of Science in Korean Medicine, Cancer Preventive Material Development Research Center, College of Korean Medicine, Kyung Hee University) Choi, Byung Hyune (Department of Advanced Biomedical Sciences, Inha University College of Medicine) |
1 | Amar, A. P. and Levy, M. L. (1999) Pathogenesis and pharmacological strategies for mitigating secondary damage in acute spinal cord injury. Neurosurgery 44, 1027-1039; discussion 1039-1040. DOI ScienceOn |
2 | Crowe, M. J., Bresnahan, J. C., Shuman, S. L., Masters, J. N. and Beattie, M. S. (1997) Apoptosis and delayed degeneration after spinal cord injury in rats and monkeys. Nat. Med. 3, 73-76. DOI ScienceOn |
3 | Sandvig, A., Berry, M., Barrett, L. B., Butt, A. and Logan, A. (2004) Myelin-, reactive glia-, and scar-derived CNS axon growth inhibitors: expression, receptor signaling, and correlation with axon regeneration. Glia 46, 225-251. DOI ScienceOn |
4 | Jones, L. L., Margolis, R. U. and Tuszynski, M. H. (2003) The chondroitin sulfate proteoglycans neurocan, brevican, phosphacan, and versican are differentially regulated following spinal cord injury. Exp. Neurol. 182, 399-411. DOI ScienceOn |
5 | Silver, J. and Miller, J. H. (2004) Regeneration beyond the glial scar. Nat. Rev. Neurosci. 5, 146-156. DOI ScienceOn |
6 | David, S. and Ousman, S. S. (2002) Recruiting the immune response to promote axon regeneration in the injured spinal cord. Neuroscientist 8, 33-41. DOI ScienceOn |
7 | Schermer, C. and Humpel, C. (2002) Granulocyte macrophage-colony stimulating factor activates microglia in rat cortex organotypic brain slices. Neurosci. Lett. 328, 180-184. DOI ScienceOn |
8 | Kim, J. K., Choi, B. H., Park, H. C., Park, S. R., Kim, Y. S., Yoon, S. H., Park, H. S., Kim, E. Y. and Ha, Y. (2004) Effects of GM-CSF on the neural progenitor cells. Neuroreport 15, 2161-2165. DOI ScienceOn |
9 | Kannan, Y., Moriyama, M., Sugano, T., Yamate, J., Kuwamura, M., Kagaya, A. and Kiso, Y. (2000) Neurotrophic action of interleukin 3 and granulocyte-macrophage colony-stimulating factor on murine sympathetic neurons. Neuroimmunomodulation 8, 132-141. DOI ScienceOn |
10 | Franzen, R., Bouhy, D. and Schoenen, J. (2004) Nervous system injury: focus on the inflammatory cytokine 'granulocyte-macrophage colony stimulating factor'. Neurosci. Lett. 361, 76-78. DOI ScienceOn |
11 | Saada, A., Reichert, F. and Rotshenker, S. (1996) Granulocyte macrophage colony stimulating factor produced in lesioned peripheral nerves induces the up-regulation of cell surface expression of MAC-2 by macrophages and Schwann cells. J. Cell Biol. 133, 159-167. DOI |
12 | Ousman, S. S. and David, S. (2001) MIP-1alpha, MCP-1, GM-CSF, and TNF-alpha control the immune cell response that mediates rapid phagocytosis of myelin from the adult mouse spinal cord. J. Neurosci. 21, 4649-4656. |
13 | Bouhy, D., Malgrange, B., Multon, S., Poirrier, A. L., Scholtes, F., Schoenen, J. and Franzen, R. (2006) Delayed GM-CSF treatment stimulates axonal regeneration and functional recovery in paraplegic rats via an increased BDNF expression by endogenous macrophages. FASEB J. 20, 1239-1241. DOI ScienceOn |
14 | Huang, X., Choi, J. K., Park, S. R., Ha, Y., Park, H., Yoon, S. H., Park, H. C., Park, J. O. and Choi, B. H. (2007) GM-CSF inhibits apoptosis of neural cells via regulating the expression of apoptosis-related proteins. Neurosci. Res. 58, 50-57. DOI ScienceOn |
15 | Ha, Y., Kim, Y. S., Cho, J. M., Yoon, S. H., Park, S. R., Yoon, D. H., Kim, E. Y. and Park, H. C. (2005) Role of granulocyte-macrophage colony-stimulating factor in preventing apoptosis and improving functional outcome in experimental spinal cord contusion injury. J. Neurosurg. 2, 55-61. DOI ScienceOn |
16 | Park, H. C., Shim, Y. S., Ha, Y., Yoon, S. H., Park, S. R., Choi, B. H. and Park, H. S. (2005) Treatment of complete spinal cord injury patients by autologous bone marrow cell transplantation and administration of granulocyte-macrophage colony stimulating factor. Tissue Engineering 11, 913-922. DOI ScienceOn |
17 | Yoon, S. H., Shim, Y. S., Park, Y. H., Chung, J. K., Nam, J. H., Kim, M. O., Park, H. C., Park, S. R., Min, B. H., Kim, E. Y., Choi, B. H., Park, H. and Ha, Y. (2007) Complete spinal cord injury treatment using autologous bone marrow cell transplantation and bone marrow stimulation with granulocyte macrophage-colony stimulating factor: Phase I/II clinical trial. Stem Cells 25, 2066-2073. DOI ScienceOn |
18 | Kim, N. K., Choi, B. H., Huang, X., Snyder, B. J., Bukhari, S., Kong, T. H., Park, H., Park, H. C., Park, S. R. and Ha, Y. (2009) Granulocyte-macrophage colony-stimulating factor promotes survival of dopaminergic neurons in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced murine Parkinson's disease model. European J. Neurosci. 29, 891-900. DOI ScienceOn |
19 | Huang, X., Kim, J. M., Kong, T. H., Park, S. R., Ha, Y., Kim, M. H., Park, H., Yoon, S. H., Park, H. C., Park, J. O., Min, B. H. and Choi, B. H. (2009) GM-CSF inhibits glial scar formation and shows long-term protective effect after spinal cord injury. J. Neurol. Sci. 277, 87-97. DOI ScienceOn |
20 | Kong, T., Choi, J. K., Park, H., Choi, B. H., Snyder, B. J., Bukhari, S., Kim, N. K., Huang, X., Park, S. R., Park, H. C. and Ha, Y. (2009) Reduction in programmed cell death and improvement in functional outcome of transient focal cerebral ischemia after administration of granulocyte-macrophage colony-stimulating factor in rats. Laboratory investigation. J. Neurosurg. 111, 155-163. DOI ScienceOn |
21 | Smith, G. M. and Strunz, C. (2005) Growth factor and cytokine regulation of chondroitin sulfate proteoglycans by astrocytes. Glia 52, 209-218. DOI ScienceOn |
22 | Monnier, P. P., Sierra, A., Schwab, J. M., Henke-Fahle, S. and Mueller, B. K. (2003) The Rho/ROCK pathway mediates neurite growth-inhibitory activity associated with the chondroitin sulfate proteoglycans of the CNS glial scar. Mol. Cell Neurosci. 22, 319-330. DOI ScienceOn |
23 | Zhang, Y. E. (2009) Non-Smad pathways in TGF-beta signaling. Cell Res. 19, 128-139. DOI ScienceOn |
24 | Guthridge, M. A., Stomski, F. C., Thomas, D., Woodcock, J. M., Bagley, C. J., Berndt, M. C. and Lopez, A. F. (1998) Mechanism of activation of the GM-CSF, IL-3, and IL-5 family of receptors. Stem Cells 16, 301-313. DOI ScienceOn |
25 | Choi, J. K., Choi, B. H., Ha, Y., Park, H., Yoon, S. H., Park, H. C. and Park, S. R. (2007) Signal transduction pathways of GM-CSF in neural cell lines. Neurosci. Lett. 420, 217-222. DOI ScienceOn |
26 | Logan, A., Berry, M., Gonzalez, A. M., Frautschy, S. A., Sporn, M. B. and Baird, A. (1994) Effects of transforming growth factor beta 1 on scar production in the injured central nervous system of the rat. Eur. J. Neurosci. 6, 355-363. DOI |
27 | Iannotti, C., Zhang, Y. P., Shields, L. B., Han, Y., Burke, D. A., Xu, X. M. and Shields, C. B. (2006) Dural repair reduces connective tissue scar invasion and cystic cavity formation after acute spinal cord laceration injury in adult rats. J. Neurotrauma 23, 853-865. DOI ScienceOn |
28 | Roitbak, T. and Sykova, E. (1999) Diffusion barriers evoked in the rat cortex by reactive astrogliosis. Glia 28, 40-48. DOI |
29 | Hynds, D. L. and Snow, D. M. (1999) Neurite outgrowth inhibition by chondroitin sulfate proteoglycan: stalling/ stopping exceeds turning in human neuroblastoma growth cones. Exp. Neurol. 160, 244-255. DOI ScienceOn |
30 | Schwab, J. M., Beschorner, R., Nguyen, T. D., Meyermann, R. and Schluesener, H. J. (2001) Differential cellular accumulation of connective tissue growth factor defines a subset of reactive astrocytes, invading fibroblasts, and endothelial cells following central nervous system injury in rats and humans. J. Neurotrauma 18, 377-388. DOI ScienceOn |
31 | Logan, A., Green, J., Hunter, A., Jackson, R. and Berry, M. (1999) Inhibition of glial scarring in the injured rat brain by a recombinant human monoclonal antibody to transforming growth factor-beta2. Eur. J. Neurosci. 11, 2367-2374. DOI ScienceOn |
32 | John, G. R., Chen, L., Rivieccio, M. A., Melendez-Vasquez, C. V., Hartley, A. and Brosnan, C. F. (2004) Interleukin-1beta induces a reactive astroglial phenotype via deactivation of the Rho GTPase-Rock axis. J. Neurosci. 24, 2837-2845. DOI ScienceOn |
33 | Lingor, P., Teusch, N., Schwarz, K., Mueller, R., Mack, H., Bahr, M. and Mueller, B. K. (2007) Inhibition of Rho kinase (ROCK) increases neurite outgrowth on chondroitin sulphate proteoglycan in vitro and axonal regeneration in the adult optic nerve in vivo. J. Neurochem. 103, 181-189. |
34 | Holmberg, E., Zhang, S. X., Sarmiere, P. D., Kluge, B. R., White, J. T. and Doolen, S. (2008) Statins decrease chondroitin sulfate proteoglycan expression and acute astrocyte activation in central nervous system injury. Exp. Neurol. 214, 78-86. DOI ScienceOn |
35 | Chan, C. C., Wong, A. K., Liu, J., Steeves, J. D. and Tetzlaff, W. (2007) ROCK inhibition with Y27632 activates astrocytes and increases their expression of neurite growth-inhibitory chondroitin sulfate proteoglycans. Glia 55, 369-384. DOI ScienceOn |
36 | Gopalakrishnan, S. M., Teusch, N., Imhof, C., Bakker, M. H., Schurdak, M., Burns, D. J. and Warrior, U. (2008) Role of Rho kinase pathway in chondroitin sulfate proteoglycan-mediated inhibition of neurite outgrowth in PC12 cells. J. Neurosci. Res. 86, 2214-2226. DOI ScienceOn |
37 | Jain, A., Brady-Kalnay, S. M. and Bellamkonda, R. V. (2004) Modulation of Rho GTPase activity alleviates chondroitin sulfate proteoglycan-dependent inhibition of neurite extension. J. Neurosci. Res. 77, 299-307. DOI ScienceOn |
38 | Just, I., Rohrbeck, A., Huelsenbeck, S. C. and Hoeltje, M. (2011) Therapeutic effects of Clostridium botulinum C3 exoenzyme. Naunyn. Schmiedebergs. Arch. Pharmacol. 383, 247-252. DOI |
39 | Asher, R. A., Morgenstern, D. A., Fidler, P. S., Adcock, K. H., Oohira, A., Braistead, J. E., Levine, J. M., Margolis, R. U., Rogers, J. H. and Fawcett, J. W. (2000) Neurocan is upregulated in injured brain and in cytokine-treated astrocytes. J. Neurosci. 20, 2427-2438. |